Mylan Laboratories, Inc. (NASDAQ:MYL)
CAPS Rating:
The Company develops, licenses, manufactures, markets and distributes generic, brand and branded generic pharmaceutical products and active pharmaceutical ingredients.
The Company develops, licenses, manufactures, markets and distributes generic, brand and branded generic pharmaceutical products and active pharmaceutical ingredients.
Recs
Generics, nice line of meds, improving stats